A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease

Summary

The purpose of this study is to assess the efficacy and safety of 24 weeks of treatment with batoclimab in adult participants with biochemically documented hyperthyroidism due to GD who have failed to achieve euthyroidism on antithyroid drugs (ATDs).

Timeline

Start

2023-05-15

Primary completion

2025-07-25

Completion

2025-07-25

Drugs

Indications